ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin
#WeareCvilleBioHub: Martin Chapman, President, Indoor Biotechnologies #WeareCvilleBioHub: Martin Chapman, President, Indoor Biotechnologies
RIVANNA® Announces Partnership with BOMImed to Increase Distribution of Accuro® in Canada RIVANNA® Announces Partnership with BOMImed to Increase Distribution of Accuro® in Canada
Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company
AMPEL BioSolutions to Present at 2021 BioHealth Capital Region Forum AMPEL BioSolutions to Present at 2021 BioHealth Capital Region Forum
Focused Ultrasound Foundation launches new open research repository. Focused Ultrasound Foundation launches new open research repository.
RIVANNA® Announces Alliance With Tri-anim Health Services To Increase Nationwide Distribution Of Accuro® RIVANNA® Announces Alliance With Tri-anim Health Services To Increase Nationwide Distribution Of Accuro®
Capital One Gives $2 Million for UVA School of Data Science Building Hub Capital One Gives $2 Million for UVA School of Data Science Building Hub
Leading Authority on Brain Tumors Joins Foundation Leading Authority on Brain Tumors Joins Foundation
Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies
